Blog

This is a guest post by Peter Croes, a 78-year-old two-time renal cancer survivor who was initially diagnosed with kidney cancer in 1993. Peter is a patient at Moffitt Cancer Center in Tampa, Florida and lived in Lakeland, FL before moving to Dillard in the northeast mountains of Georgia in 2022. He returns to Moffitt, with Jeanie, his wife, for…

This is a guest post by David Miller, 61, a hospitality consultant and kidney cancer survivor based in Freehold, New Jersey. Growing up, my dad — Lewis Miller — was my hero. He was the person I looked up to, admired, and modeled myself after. He owned his own business, worked tirelessly, and rarely ever slowed down. He was always…

This is a guest post by Sarah Tuck, KCA’s Senior Manager of Patient Programs, who works on all the patient programs and education initiatives. I had the privilege of attending Stupid Cancer’s CancerCon in Washington, D.C. on August 23 on behalf of the Kidney Cancer Association (KCA). The conference brought together patients, survivors, caregivers, advocates, non-profit and health care professionals…

Cures don’t happen overnight. Research is slow. Step by step, each new discovery builds on all the discoveries that were made before. These might range from identifying a single, potentially cancer-causing genetic mutation to proving a new drug can target and kill cancer cells. Those really exciting research breakthroughs, the kinds that get written about in the news - like…

The newly launched Pediatric Renal Tumor Coalition (PRTC) brings together leading experts and national organizations focused on childhood cancer research and advocacy to accelerate progress for children diagnosed with kidney cancers. Founding members of the PRTC include the Kidney Cancer Association (KCA), Joey’s Wings Foundation, Wilms Cancer Foundation (WCF), Elevate Childhood Cancer Research and Advocacy (Elevate), and Kelly Trout, BSN,…

In a recent episode of the Cancer Interviews podcast, Nicole Scott — member of the Kidney Cancer Association’s Patient & Caregiver Advisory Council — shared her story of becoming a caregiver when her husband, Keith, was diagnosed with papillary renal cell carcinoma. https://www.youtube.com/watch?v=ajztvAkUeGE&t=206s&pp=ygUibmljb2xlIHNjb3R0IHRoZSBjYW5jZXIgaW50ZXJ2aWV3cw%3D%3D Nicole and Keith worked together at the same Ohio hospital when Keith began experiencing pain in his…

The end of May each year signals the beginning of summer and the ASCO Annual Meeting in Chicago. The Kidney Cancer Association’s Clinical Advisory Board (CAB) members conducted reviews of the kidney cancer discussions at this year's meeting for the entire kidney cancer clinical team. Read on to learn more! Results Reporting final efficacy and safety data in the intent-to-treat…

Dr. Eric Kauffman received a Kidney Cancer Association Research Award in 2021 for a project called “Biology of spontaneously regressing renal cell carcinoma primary tumors” that looked at how and why some kidney tumors shrink on their own, without treatment. Here, KCA’s Chief Scientific Officer, Dr. Salvatore La Rosa, shares some recent updates and learnings from Dr. Kauffman’s research. A…

Two investigators recently received funding from the Cancer Research Institute (CRI) for research on improved immunotherapy approaches to treating kidney cancer. CRI awarded these investigators in addition to a joint Kidney Cancer Association-CRI award earmarked to fund a kidney cancer project. https://www.kidneycancer.org/qa-david-braun/ Dr. David Braun, a medical oncologist and Assistant Professor of Medicine at the Yale School of Medicine, was…

Sidi Chen, PhD, was named the 2025 Kidney Cancer Association-Cancer Research Institute Clinic and Laboratory Integration Program (CLIP) Investigator to research "Initial development of a CAR-T-drug conjugate against solid tumor and application in kidney cancer." Dr. Chen, Associate Professor of Genetics and of Neurosurgery at the Yale School of Medicine, plans to pair chimeric antigen receptor (CAR)-T-cell therapy, which has…